Drugs / Autologous Dendritic Cell HIV Vaccination
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00056758 | Feb 2003 → ? | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous Dendritic Cell HIV Vaccination | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00056758 ↗ |
| Modality | Vaccine | “dendritic cell vaccination” NCT00056758 ↗ |
| Route | Intravenous | “These cells will be administered back to the patient either into a vein (intravenously) or the skin (subcutaneously).” NCT00056758 ↗ |
| Route | Subcutaneous | “These cells will be administered back to the patient either into a vein (intravenously) or the skin (subcutaneously).” NCT00056758 ↗ |